Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

NCT06679816 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

882

Enrollment

OTHER

Sponsor class

Conditions

Pituitary Adenoma
Pituitary Neuroendocrine Tumor

Interventions

DRUG: Hormone replacement therapy
DRUG: Placebo

Sponsor

Beijing Tiantan Hospital